Intraocular Drug Delivery

Explores the complex landscape of intraocular drug delivery, detailing the scientific, regulatory, and clinical hurdles involved in treating posterior eye diseases. The authors examine various sustained-release mechanisms, including nondegradable implants, biodegradable polymers, and innovative encapsulated cell technologies designed to provide long-term therapeutic effects. Specific focus is placed on the pharmacokinetics of the eye, highlighting how diffusion and partitioning influence the movement of medication through ocular tissues. The source further discusses advanced interventions such as gene therapy and laser-targeted delivery for conditions like macular degeneration and proliferative vitreoretinopathy. Ultimately, the material emphasizes the necessity of rigorous clinical trials and FDA oversight to ensure that these high-risk ophthalmic treatments are both safe and effective.Get the Book now from Amazon:https://www.amazon.com/Intraocular-Drug-Delivery-Glenn-Jaffe/dp/0367453819?&linkCode=ll1&tag=cvthunderx-20&linkId=c98edf6db73ab369c4bcaa31940713cb&language=en_US&ref_=as_li_ss_tlYou can listen and download our episodes for free on more than 10 different platforms:https://linktr.ee/pharmacy_simpleProduced by:https://www.podcaistudio.com/